The UK has approved Foundayo, a once-daily oral GLP-1 medicine from Eli Lilly, making it the first country in Europe to authorise the treatment for obesity-related weight loss and type 2 diabetes, with availability through private prescription later this month.…
Dr Kelvin Candiago highlights the importance of sustained lifestyle changes for type 2 diabetes recovery. His new mGanik Care clinic in Gading Serpong seeks to provide tailored, comprehensive support to improve long-term outcomes and increase remission chances. For many people…
Novo Nordisk has begun supplying Awiqli, its first-of-its-kind once-weekly basal insulin, across US pharmacies, promising a significant shift in type 2 diabetes treatment options after receiving FDA approval. Novo Nordisk has begun supplying Awiqli, its once-weekly basal insulin, to pharmacies…
A team in Hong Kong has developed a microneedle patch that uses ultrasound to track blood glucose levels, offering a low-cost, enzyme-free alternative to traditional sensors with potential applications for broader health monitoring. Researchers in Hong Kong say they have…
Recent studies indicate that antibiotics can alter gut bacteria in ways that potentially affect blood sugar regulation, especially in those with existing metabolic conditions, though effects vary and more research is needed. Antibiotics can sometimes do more than clear an…
New research employing advanced imaging techniques finds that changes in both outer and inner bone structures contribute to higher fracture risks in older adults with type 2 diabetes, challenging reliance on bone density alone for risk assessment. A new study…
Steve Harr outlines four critical questions for Sana Biotechnology’s gene-modified islet cell therapy to revolutionise type 1 diabetes treatment, highlighting challenges in efficacy, manufacturing scale, safety, and economics. Steve Harr has set out four questions he believes will determine whether…
FibroBiologics has obtained a US patent aimed at improving pancreatic islet transplantation, marking a significant scientific milestone in its developing cell-based therapies for Type 1 diabetes amid broader research in regenerative medicine. FibroBiologics has taken another step in building out…
New research indicates that restoring body mass index to a healthy range in individuals with early-stage type 1 diabetes could significantly lower their risk of developing full-blown clinical disease, highlighting the importance of weight management in early intervention strategies. New…
Research from TrialNet indicates that restoring BMI to a healthy range in overweight or obese children and adolescents with early-stage type 1 diabetes could reduce their likelihood of disease progression, highlighting weight management as a modifiable factor in disease risk.…
